These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 37928545)

  • 1. Novel insights into IL-37: an anti-inflammatory cytokine with emerging roles in anti-cancer process.
    Gu M; Jin Y; Gao X; Xia W; Xu T; Pan S
    Front Immunol; 2023; 14():1278521. PubMed ID: 37928545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Understanding of IL-37 in Human Health and Disease.
    Su Z; Tao X
    Front Immunol; 2021; 12():696605. PubMed ID: 34248996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight into interleukin-37: The potential therapeutic target in allergic diseases.
    Huang Z; Xie L; Li H; Liu X; Bellanti JA; Zheng SG; Su W
    Cytokine Growth Factor Rev; 2019 Oct; 49():32-41. PubMed ID: 31672283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-37: An anti-inflammatory cytokine with antitumor functions.
    Mei Y; Liu H
    Cancer Rep (Hoboken); 2019 Apr; 2(2):e1151. PubMed ID: 32935478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-37 As a Potential Biotherapeutics of Inflammatory Diseases.
    Bai J; Li Y; Li M; Tan S; Wu D
    Curr Drug Targets; 2020; 21(9):855-863. PubMed ID: 32348214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging role of interleukin-37 in cardiovascular diseases.
    Zhuang X; Wu B; Li J; Shi H; Jin B; Luo X
    Immun Inflamm Dis; 2017 Sep; 5(3):373-379. PubMed ID: 28548248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of inflammation and acquired immunity by IL-37.
    Cavalli G; Dinarello CA
    Immunol Rev; 2018 Jan; 281(1):179-190. PubMed ID: 29247987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Tumor Microenvironment by Intervention in Interleukin-1 Biology.
    Voronov E; Apte RN
    Curr Pharm Des; 2017; 23(32):4893-4905. PubMed ID: 28606052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A protective role of IL-37 in cancer: a new hope for cancer patients.
    Abulkhir A; Samarani S; Amre D; Duval M; Haddad E; Sinnett D; Leclerc JM; Diorio C; Ahmad A
    J Leukoc Biol; 2017 Feb; 101(2):395-406. PubMed ID: 27881603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells.
    Conti P; Carinci F; Lessiani G; Spinas E; Kritas SK; Ronconi G; Caraffa A; Theoharides TC
    Immunol Res; 2017 Oct; 65(5):982-986. PubMed ID: 28748328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction.
    Nold-Petry CA; Lo CY; Rudloff I; Elgass KD; Li S; Gantier MP; Lotz-Havla AS; Gersting SW; Cho SX; Lao JC; Ellisdon AM; Rotter B; Azam T; Mangan NE; Rossello FJ; Whisstock JC; Bufler P; Garlanda C; Mantovani A; Dinarello CA; Nold MF
    Nat Immunol; 2015 Apr; 16(4):354-65. PubMed ID: 25729923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulated mast cells release inflammatory cytokines: potential suppression and therapeutical aspects.
    Varvara G; Tettamanti L; Gallenga CE; Caraffa Al; D'Ovidio C; Mastrangelo F; Ronconi G; Kritas SK; Conti P
    J Biol Regul Homeost Agents; 2018; 32(6):1355-1360. PubMed ID: 30574739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of IL-37 in skin and connective tissue diseases.
    Pan Y; Wen X; Hao D; Wang Y; Wang L; He G; Jiang X
    Biomed Pharmacother; 2020 Feb; 122():109705. PubMed ID: 31918276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies.
    Conti P; Ronconi G; Caraffa A; Gallenga CE; Ross R; Frydas I; Kritas SK
    J Biol Regul Homeost Agents; 2020 March-April,; 34(2):327-331. PubMed ID: 32171193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell in innate immunity mediated by proinflammatory and antiinflammatory IL-1 family members.
    Robuffo I; Toniato E; Tettamanti L; Mastrangelo F; Ronconi G; Frydas I; Caraffa Al; Kritas SK; Conti P
    J Biol Regul Homeost Agents; 2017; 31(4):837-842. PubMed ID: 29254286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis.
    Ge Y; Huang M; Yao YM
    Cytokine Growth Factor Rev; 2019 Feb; 45():24-34. PubMed ID: 30587411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual role of IL-37 in the progression of tumors.
    Zhu Y; Qin H; Ye K; Sun C; Qin Y; Li G; Wang H; Wang H
    Cytokine; 2022 Feb; 150():155760. PubMed ID: 34800851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP.
    Fabbi M; Carbotti G; Ferrini S
    J Leukoc Biol; 2015 Apr; 97(4):665-75. PubMed ID: 25548255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines.
    Sharma S; Kulk N; Nold MF; Gräf R; Kim SH; Reinhardt D; Dinarello CA; Bufler P
    J Immunol; 2008 Apr; 180(8):5477-82. PubMed ID: 18390730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.